Anal Bioanal Chem. 2008 Jan;390(1):141-54. Epub 2007 Nov 7.

New technologies around biomarkers and their interplay with drug development.

Source

Novartis Pharma AG, Development, 4002, Basel, Switzerland. frank.dieterle@novartis.com

Abstract

What conductors are to their orchestras, biomarkers are to their associated technologies. Building fundamental science, supporting early diagnosis of diseases and following their progression, improving efficacy and safety of treatments, optimizing patient selection and adapting dosing of drugs, helping decide which therapy is most appropriate; these are examples of a few contexts in which biomarkers are key players. Technology development can definitely not escape being associated with these steps. In other words, today's biomarkers are the thermometers of tomorrow's therapies. This review provides an overview of recently established platforms as well as new and upcoming technologies for biomarker development in the context of drug development. The roles as well as the pros and cons of different disciplines such as genetics, genomics, proteomics, metabonomics, and assay development will be discussed.

PMID:: 17987283; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Biological Markers

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

Review Development and use of biomarkers in oncology drug development. [Toxicol Pathol. 2004]
Review Development and use of biomarkers in oncology drug development.
Floyd E, McShane TM. Toxicol Pathol. 2004 Mar-Apr; 32 Suppl 1:106-15.
Review Biomarker discovery and validation: technologies and integrative approaches. [Trends Biotechnol. 2004]
Review Biomarker discovery and validation: technologies and integrative approaches.
Ilyin SE, Belkowski SM, Plata-Salamán CR. Trends Biotechnol. 2004 Aug; 22(8):411-6.
Review Promises of biomarkers in drug development--a reality check. [Chem Biol Drug Des. 2007]
Review Promises of biomarkers in drug development--a reality check.
Marrer E, Dieterle F. Chem Biol Drug Des. 2007 Jun; 69(6):381-94.
Novel biomarkers of acute kidney toxicity. [Clin Pharmacol Ther. 2009]
Novel biomarkers of acute kidney toxicity.
Goodsaid FM, Blank M, Dieterle F, Harlow P, Hausner E, Sistare F, Thompson A, Vonderscher J. Clin Pharmacol Ther. 2009 Nov; 86(5):490-6. Epub 2009 Aug 26.
The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics. [Toxicol Lett. 2009]
The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M, Arteta D, Guerrero MJ, Fernandez-Orth D, Simón L, Martinez A. Toxicol Lett. 2009 Apr 10; 186(1):45-51. Epub 2008 Oct 28.

See reviews... See all...

Cited by 3 PubMed Central articles

Review Biomarkers of immunotoxicity for environmental and public health research. [Int J Environ Res Public Health. 2011]
Review Biomarkers of immunotoxicity for environmental and public health research.
Duramad P, Holland NT. Int J Environ Res Public Health. 2011 May; 8(5):1388-401. Epub 2011 May 6.
Differential protein expression in human corneal endothelial cells cultured from young and older donors. [Mol Vis. 2008]
Differential protein expression in human corneal endothelial cells cultured from young and older donors.
Zhu C, Rawe I, Joyce NC. Mol Vis. 2008; 14:1805-14. Epub 2008 Sep 30.
Review Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices. [Electrophoresis. 2008]
Review Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices.
Guzman NA, Blanc T, Phillips TM. Electrophoresis. 2008 Aug; 29(16):3259-78.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

New technologies around biomarkers and their interplay with drug development.
New technologies around biomarkers and their interplay with drug development.
Anal Bioanal Chem. 2008 Jan ;390(1):141-54. Epub 2007 Nov 7 .

PubMed
The relationship between migraine and mental disorders in a population-based sam...
The relationship between migraine and mental disorders in a population-based sample.
Gen Hosp Psychiatry. 2009 Jan-Feb ;31(1):14-9. Epub 2008 Oct 9 .

PubMed
Meta-analysis of the diagnostic performance of stress perfusion cardiovascular m...
Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease.
J Cardiovasc Magn Reson. 2010 May 19 ;12(1):29.

PubMed
Shorter difference between myocardium and blood optimal inversion time suggests ...
Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy.
J Magn Reson Imaging. 2009 Nov ;30(5):967-72.

PubMed
Comparison of bioactive glass to demineralized freeze-dried bone allograft in th...
Comparison of bioactive glass to demineralized freeze-dried bone allograft in the treatment of intrabony defects around implants in the canine mandible.
J Periodontol. 1999 May ;70(5):526-35.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: